These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 21673038
1. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania. West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC. J Infect Dis; 2011 Jul 15; 204(2):268-73. PubMed ID: 21673038 [Abstract] [Full Text] [Related]
6. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. Cajas-Monson LC, Mkocha H, Muñoz B, Quinn TC, Gaydos CA, West SK. PLoS Negl Trop Dis; 2011 Mar 15; 5(3):e978. PubMed ID: 21423645 [Abstract] [Full Text] [Related]
7. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? West SK, Moncada J, Munoz B, Mkocha H, Storey P, Hardick J, Gaydos CA, Quinn TC, Schachter J. J Infect Dis; 2014 Jul 01; 210(1):65-71. PubMed ID: 24446528 [Abstract] [Full Text] [Related]
8. Mass treatment with single-dose azithromycin for trachoma. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC. N Engl J Med; 2004 Nov 04; 351(19):1962-71. PubMed ID: 15525721 [Abstract] [Full Text] [Related]
9. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK. PLoS Negl Trop Dis; 2014 Apr 04; 8(4):e2761. PubMed ID: 24722392 [Abstract] [Full Text] [Related]
11. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD, PRET Partnership. PLoS Negl Trop Dis; 2012 Apr 04; 6(4):e1586. PubMed ID: 22545165 [Abstract] [Full Text] [Related]
12. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R, Partnership for Rapid Elimination of Trachoma (PRET) study group. PLoS Negl Trop Dis; 2013 Apr 04; 7(6):e2115. PubMed ID: 23785525 [Abstract] [Full Text] [Related]
17. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control. West SK, Munoz BE, Mkocha H, Gaydos C, Quinn T. Ophthalmic Epidemiol; 2015 Apr 04; 22(3):170-5. PubMed ID: 26158574 [Abstract] [Full Text] [Related]